SCHEMBL21143403

SCHEMBL21143403

C[C@]12C[C@H](c3ccc(NC(=O)O)cc3)[C@H]3[C@@H](CCC4=CC5(CC[C@@H]43)SCCS5)[C@@H]1CCC2O

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PDK1 Q15118 2/20 0.39
▸ PDK2 Q15119 2/20 0.39
▸ PDK3 Q15120 2/20 0.39
▸ PDK4 Q16654 2/20 0.39
▸ SLC22A1 O15245 1/20 0.34
▸ ALDH1A1 P00352 1/20 0.34
▸ SHBG P04278 1/20 0.34
▸ SERPINA6 P08185 1/20 0.34
▸ THRB P10828 1/20 0.34
▸ NR3C1 P04150 1/20 0.34
▸ ESR1 P03372 9/20 0.33
▸ ESR2 Q92731 6/20 0.33
▸ LMNA P02545 3/20 0.33
▸ PGR P06401 1/20 0.33
▸ ADORA3 P0DMS8 1/20 0.33
▸ AR P10275 1/20 0.33
▸ CHRM1 P11229 1/20 0.33
▸ TBXA2R P21731 1/20 0.33
▸ ADRA1A P35348 1/20 0.33
▸ OPRM1 P35372 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23131063 0.89 PDK1 (0.34) PDK1PDK2PDK3PDK4SLC22A1
SCHEMBL20048423 0.89 PDK1 (0.34) PDK1PDK2PDK3PDK4SLC22A1
SCHEMBL20048102 0.87 PDK1 (0.34) PDK1PDK2PDK3PDK4SLC22A1
SCHEMBL20048097 0.87 PDK1 (0.34) PDK1PDK2PDK3PDK4SLC22A1
SCHEMBL21729782 0.86 PDK1 (0.34) PDK1PDK2PDK3PDK4SLC22A1
SCHEMBL8539498 0.86 PDK1 (0.37) PDK1PDK2PDK3PDK4SLC22A1
SCHEMBL21143415 0.86 ESR1 (0.37) PDK1PDK2PDK3PDK4SLC22A1
SCHEMBL20048225 0.86 ESR1 (0.37) PDK1PDK2PDK3PDK4SLC22A1
SCHEMBL20048226 0.86 ESR1 (0.37) PDK1PDK2PDK3PDK4SLC22A1
SCHEMBL9019868 0.85 PDK1 (0.36) PDK1PDK2PDK3PDK4SLC22A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230096870-A1 INHIBITORS OF GLUCOCORTICOID RECEPTOR ORIC PHARMACEUTICALS, INC. 2023-03-30 — — US disclosed
EP-3851444-A1 INHIBITORS OF GLUCOCORTICOID RECEPTOR Oric Pharmaceuticals, Inc. (US) 2021-07-21 — — EP disclosed
EP-3523315-B1 INHIBITOR OF GLUCOCORTICOID RECEPTOR ORIC PHARMACEUTICALS INC (US) 2021-03-24 — — EP disclosed
US-20210017219-A1 INHIBITORS OF GLUCOCORTICOID RECEPTOR ORIC PHARMACEUTICALS, INC. 2021-01-21 — — US disclosed
US-10836789-B2 Inhibitors of glucocorticoid receptor ORIC PHARMACEUTICALS, INC. (US) 2020-11-17 — — US disclosed
US-20200291058-A1 INHIBITORS OF GLUCOCORTICOID RECEPTOR ORIC PHARMACEUTICALS, INC. 2020-09-17 — — US disclosed
US-10723759-B2 Inhibitors of glucocorticoid receptor ORIC PHARMACEUTICALS, INC. (US) 2020-07-28 — — US disclosed
US-20200055892-A1 INHIBITORS OF GLUCOCORTICOID RECEPTOR ORIC PHARMACEUTICALS, INC. 2020-02-20 — — US disclosed
US-10472387-B2 Inhibitors of glucocorticoid receptor ORIC PHARMACEUTICALS, INC. (US) 2019-11-12 — — US disclosed
US-20190218246-A1 INHIBITORS OF GLUCOCORTICOID RECEPTOR ORIC PHARMACEUTICALS, INC. 2019-07-18 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10472387-B2 Inhibitors of glucocorticoid receptor NR3C1, NR3C2, MC2R PDK1 1017/4885PDK2 1303/4885PDK3 1428/4885
US-20190218246-A1 INHIBITORS OF GLUCOCORTICOID RECEPTOR NR3C1, NR3C2, MC2R PDK1 1017/4885PDK2 1303/4885PDK3 1428/4885
US-20210017219-A1 INHIBITORS OF GLUCOCORTICOID RECEPTOR NR3C1, NR3C2, MC2R PDK1 1017/4885PDK2 1303/4885PDK3 1428/4885
US-20200055892-A1 INHIBITORS OF GLUCOCORTICOID RECEPTOR NR3C1, NR3C2, MC2R PDK1 1017/4885PDK2 1303/4885PDK3 1428/4885
US-10836789-B2 Inhibitors of glucocorticoid receptor NR3C1, NR3C2, MC2R PDK1 1017/4885PDK2 1303/4885PDK3 1428/4885
US-10723759-B2 Inhibitors of glucocorticoid receptor NR3C1, NR3C2, MC2R PDK1 1017/4885PDK2 1303/4885PDK3 1428/4885
US-20200291058-A1 INHIBITORS OF GLUCOCORTICOID RECEPTOR NR3C1, NR3C2, MC2R PDK1 1017/4885PDK2 1303/4885PDK3 1428/4885
US-20230096870-A1 INHIBITORS OF GLUCOCORTICOID RECEPTOR NR3C1, NR3C2, MC2R PDK1 1017/4885PDK2 1303/4885PDK3 1428/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback